The BH3 mimetic ABT737 induces autophagy by competitively disrupting the inhibitory interaction between the BH3 domain of Beclin 1 and the anti-apoptotic proteins Bcl-2 and Bcl-X L , thereby stimulating the Beclin 1-dependent allosteric activation of the pro-autophagic lipid kinase VPS34. Here, we examined whether ABT737 stimulates other pro-autophagic signal-transduction pathways. ABT737 caused the activating phosphorylation of AMP-dependent kinase (AMPK) and of the AMPK substrate acetyl CoA carboxylase, the activating phosphorylation of several subunits of the inhibitor of NF-jB (IjB) kinase (IKK) and the hyperphosphorylation of the IKK substrate IjB, inhibition of the activity of mammalian target of rapamycin (mTOR) and consequent dephosphorylation of the mTOR substrate S6 kinase. In addition, ABT737 treatment dephosphorylates (and hence likewise inhibits) p53, glycogen synthase kinase-3 and Akt. All these effects were shared by ABT737 and another structurally unrelated BH3 mimetic, HA14-1. Functional experiments revealed that pharmacological or genetic inhibition of IKK, Sirtuin and the p53-depleting ubiquitin ligase MDM2 prevented ABT737-induced autophagy. These results point to unexpected and pleiotropic proautophagic effects of BH3 mimetics involving the modulation of multiple signalling pathways.
Introduction
Macroautophagy (that we refer to as 'autophagy') is a catabolic pathway that culminates in the degradation and recycling of cytoplasmic organelles or portions of the cytosol (Klionsky, 2007) . Autophagy starts with the formation of double-membrane structures that sequester parts of the cytoplasm and close to form autophagosomes. The subsequent fusion of autophagosomes with lysosomes leads to the degradation of their luminal content, and the end products of this catabolic reaction can then be recycled to maintain cellular homeostasis (Levine and Kroemer, 2008) . Although autophagosomes are often found in the cytoplasm of dying cells, coining the term 'autophagic cell death' (Galluzzi et al., 2007; Galluzzi et al., 2008) , autophagy mostly subserves a cytoprotective function, and its suppression can precipitate the demise of stressed cells (Boya et al., 2005; Iwata et al., 2005; Degenhardt et al., 2006; Apel et al., 2008) . The functional link between autophagy and cell death, in particular Bcl-2-regulated apoptotic death, has been extensively characterized (Maiuri et al., 2007a; Sinha and Levine, 2008) . Beclin 1 regulates autophagy in a multiprotein complex, which includes class III phosphatidylinositol-3-kinase activity that participates in autophagosome nucleation. In this complex, Beclin 1 interacts with several proteins including Bcl-2, a protein initially characterized as an apoptosis inhibitor (Maiuri et al., 2007a; Sinha and Levine, 2008) .
Bcl-2 constitutes the prototype of a family of proteins containing at least one Bcl-2 homology (BH) region. The Bcl-2 family can be divided into anti-apoptotic multi-domain proteins (prototypes: Bcl-2, Bcl-X L and Mcl-1), which contain four BH domains (numbered BH1-BH4), pro-apoptotic multi-domain proteins (prototypes: Bax and Bak), which contain three BH domains (BH1, BH2 and BH3), and the pro-apoptotic BH3-only protein family (which has more than a dozen members) (Petros et al., 2004) . The relative abundance of pro-and anti-apoptotic Bcl-2 proteins dictates the propensity of cells to undergo mitochondrial membrane permeabilization and to succumb to distinct apoptosis inducers (Huang and Strasser, 2000; Galluzzi et al., 2008) .
Multidomain anti-apoptotic Bcl-2 proteins possess a hydrophobic cleft at their surface, the BH3-binding groove, which can accommodate BH3 domains from pro-apoptotic Bcl-2 protein family members. The BH3 domains from pro-apoptotic proteins can be structurally defined as four-turn amphipathic a-helices that are contained in a sequence motif that lacks invariable amino acids: Hy-X-X-X-Hy-X-X-X-Sm-D/E-X-Hy, where Hy represents hydrophobic residues and Sm represents small residues, typically glycine (Sinha and Levine, 2008) . The extreme variability of both proapoptotic BH3 domains, as well as that of the residues lining the BH3-binding groove of the anti-apoptotic proteins, determines a large heterogeneity in the affinities for each specific pair of interactions. These variable affinities, combined with the spatial and temporal variations in the concentration of each of these proteins, regulate the stoichiometry of these interactions. Thus, changing the concentration of just one BH3 domain-containing protein can affect multiple protein-protein interactions among Bcl-2 family proteins, thereby transmitting a pro-apoptotic signal throughout the network of Bcl-2-like proteins (Sinha and Levine, 2008) . Some pharmacological components such as ABT737 are referred to as 'BH3 mimetics' because they occupy the BH3-binding grooves of antiapoptotic proteins from the Bcl-2 family. ABT737 binds to Bcl-2 and Bcl-X L (but not Mcl-1) and can kill cells, provided that they express pro-apoptotic multi-domain proteins (such as Bax and Bak), which are essential for the apoptotic mitochondrial membrane permeabilization, as well as BH3-only proteins, which-once liberated from the BH3-binding cleft of Bcl-2 or Bcl-X L -can activate Bax and/or Bak (Oltersdorf et al., 2005) .
Recently, a region including amino acids 112-123 from the autophagic regulatory protein Beclin 1 has been identified as a BH3 domain (Oberstein et al., 2007; Maiuri et al., 2007b, c) . This domain in Beclin 1 is the minimal sequence necessary for the interaction with the anti-apoptotic Bcl-2 family of proteins (in particular Bcl-2 itself, Bcl-X L and Mcl-1). Although Beclin 1 is a BH3-only protein, it has no pro-apoptotic effects (Boya and Kroemer, 2009) , perhaps because it has a low affinity for other Bcl-2 family members (Sinha and Levine, 2008) . The BH3 domains of other BH3-only proteins such as Bad, as well as BH3-mimetic compounds such as ABT737, competitively disrupt the inhibitory interaction between Beclin 1 and Bcl-2/Bcl-X L , thus allowing Beclin 1 to accomplish its autophagic stimulatory functions. Only ER-targeted (not mitochondrion-targeted) Bcl-2/Bcl-X L can inhibit autophagy induced by Beclin 1, and only Beclin 1-Bcl-2/Bcl-X L complexes present in the ER (but not those present on mitochondria) are disrupted by ABT737, suggesting that Beclin 1-Bcl-2/Bcl-X L complexes that usually suppress autophagy are specifically located in the ER (Maiuri et al., 2007b, c) . This particular spatial organization may explain why Beclin 1 lacks any pro-apoptotic activity.
Hence, in cells that are resistant to its pro-apoptotic effect, ABT737 can induce autophagy because it liberates Beclin 1 from its inhibitory interaction with Bcl-2 or Bcl-X L , thus allowing Beclin 1 to support the class III phosphatidylinositol-3-kinase activity of Vps34 (Maiuri et al., 2007b, c) . Similar findings have been obtained using other BH3 mimetics (Kessel and Reiners, 2007; Lian et al., 2010) . These results suggest that ABT737 induces autophagy solely by its effects on the Beclin 1 interactome. Nonetheless, autophagy is a complex process that is regulated by multiple protein complexes beyond that organized around Beclin 1. Thus, energy sensors including AMP-dependent kinase (AMPK), mammalian target of rapamycin (mTOR) (Yang and Klionsky, 2010) , Sirtuin1 (Lee et al., 2008) , as well as stress-integrating pathways such as those involving the inhibitor of NF-kB (IkB) kinases (IKK) (Criollo et al., 2010) and the tumor suppressor protein p53 (Maiuri et al., 2009) all have a major impact on the regulation of autophagy Madeo et al., 2010) . In many paradigms of autophagic stimulation including nutrient starvation, positive regulators of autophagy (such as AMPK, SIRT1, IKK) must come into action while negative regulators (such as mTOR and cytoplasmic p53) must be inactivated for the optimal induction of autophagy. At present, it is elusive whether ABT737 affects these pathways.
Based on these premises and incognita, we decided to measure the possible effects of ABT737 on multiple distinct autophagy regulators. Our results reveal that, in contrast to our initial expectation, ABT737 must stimulate multiple pro-autophagic pathways to be optimally efficient, thus illustrating the complex interconnections among autophagy-regulatory proteins.
Results

ABT737-induced autophagy involves the AMPK, mTOR and IKK pathways
In cells that are resistant to its apoptosis-inducing effect, such as U2OS cells (Figures 1a and b) , HeLa cells ( Figure 1e ; Maiuri et al., 2007b) and HCT116 cells (Figure 1c ), ABT737 induces autophagy, as determined by following the redistribution of green fluorescent protein (GFP)-LC3 from a diffuse to a punctate pattern (Figures 1a-c) or by assessing the lipidation of endogenous LC3 protein by immunoblot . ABT737 induced a further increase in GFP-LC3 redistribution and LC3 lipidation in the presence of bafilomycin A1 (Figures 1c and d) , which inhibits the final stage of autophagic protein degradation, confirming that ABT737 increases autophagic flux. In accord with this conclusion, ABT737 reduced the abundance of the autophagic substrate p62 in all cell lines considered (Figures 2a-c) . Consistent with the published finding that ABT737 induces autophagy via the Beclin 1 complex (Maiuri et al., 2007b, c) , the knockdown of Vps34 (which is the enzymatic subunit of the Beclin 1 complex, a type 3 phoshatidylinositol-3 kinase) (Sinha and Levine, 2008) inhibited ABT737-induced autophagy evaluated by LC3 lipidation and p62 degradation ( Figure 1e) .
Next, we determined whether ABT737 stimulates additional pro-autophagic pathways by assessing its effects on the phosphorylation status of AMPKa and that of its substrate acyl-CoA carboxylase (ACC), the phosphorylation of mTOR and that of its substrate p70 S6K , as well as the phosphorylation of the IKK subunits, IKKa, IKKb and NEMO (Figure 2 ). Although the kinetics of these effects were different among the cell lines, ABT737 consistently induced the hyperphosphorylation of AMPKa and the three IKK subunits, as well as a consistent reduction in the phosphorylation of mTOR. These changes were paralleled by alterations in the phosphorylation status of the AMPKa substrate ACC, the IKK substrate IkBa (which are both hyperphosphorylated) and the mTOR substrate p70 S6K (which is hypophosphorylated upon ABT737 treatment), consistent with the interpretation that ABT737 stimulates the activation of AMPK, yet inhibits mTOR. Altogether, these results indicate that ABT737 has pleiotropic effects on several autophagyrelevant signal-transduction pathways.
Role of AMPK and mTOR in ABT737-induced autophagy ABT737 is able to induce the hyperphosphorylation of AMPKa, as well as the phosphorylation of the AMPKa substrate ACC and autophagy at a dose around 1 mM (Figure 3a ). The concentrations of ABT737 needed to induce autophagy on cells are higher than those required for Bcl-2 blockade (in cell-free systems). Thus, we decided to analyze whether AMPK activation is required for the pro-autophagic activity of ABT737. Small interfering RNA (siRNA)-mediated depletion of AMPKa reduced the ABT737-induced LC3 lipidation and p62 degradation ( Figure 3b ) in each of the three cell lines tested (shown for HCT116 cells in Figures 3a  and b) . Moreover, ATP cellular levels progressively decreased after ABT737 treatment, which likely accounts for the observed ABT737-dependent AMPK activation (Supplementary Figure 1A) . Given that ABT737 also induced a consistent decrease in mTOR activity, we then investigated whether the inhibition of mTOR is a necessary step in the induction of autophagy by ABT737. For this purpose, we overexpressed a constitutive active form of Rheb (Rheb Q64L), which positively regulates mTOR, as showed by the phosphorylation status of the mTOR substrate p70 S6K (which is hypophosphorylated upon ABT737 treatment) (Supplementary Figure 1A ). The expression of Rheb Q64L restored the activity of mTOR and prevented the BH3 mimetics and autophagic pathways SA Malik et al autophagy induction by ABT737. In contrast, the expression of a dominant-negative form of Rheb (Rheb D60K) did not affect the level of autophagy induced by ABT737 (Figure 3c ). Altogether these data confirm that ABT737-mediated stimulation of autophagy requires both AMPK activation and mTOR inhibition.
Functional implication of IKK in ABT737-induced autophagy The IKK inhibitor Bay11-7082 (Pierce et al., 1997) , as well as the HSP90 inhibitors geldanamycin and 17-allylamino-geldanamycin, which can also inhibit IKK (Broemer et al., 2004) , were previously identified as inhibitors of starvation-induced autophagy (Criollo et al., 2010) . We found that all three inhibitors also prevented the ABT737-stimulated lipidation of LC3 (Figure 4a ) and the redistribution of GFP-LC3 to autophagic puncta in all three cell lines included in this study (Figure 4b Figures 4c-f) . Surprisingly, we noted that depletion of Atg5 or that of Beclin 1 abolished the hyperphosphorylation of IKKa/b, NEMO and IkBa (Figure 4g ), suggesting an intimate link between IKK activation and autophagy. Inhibitor of NF-kB (IkB) kinase is required for ABT737-induced autophagy, but autophagy is also necessary for IKK activation.
Implication of p53 and SIRT1 in ABT737-induced autophagy We investigated the contribution of p53 to ABT737-induced autophagy, based on the recent observation that cytoplasmic p53 must be ubiquitinylated by MDM2 and then degraded by proteasomes to allow the induction of starvation-induced autophagy (Tasdemir et al., 2008a) . Similarly, SIRT1 is required for autophagy induced by nutrient shortage . Pharmacological inhibition of MDM2 with RITA or Nutlin-3 prevented the degradation of p53 (Tasdemir et al., 2008a) and concomitantly prevented the induction of autophagy in HCT116 cells induced by ABT737 (Figure 5a) . Similarly, proteasome inhibition by MG132 resulted in the maintenance of high p53 levels (Tasdemir et al., 2008a) and the inhibition of ABT737-induced autophagy (Figure 5a ). SIRT1 inhibition by EX527 also prevented the induction of LC3 lipidation in ABT737-treated HCT116 cells (Figure 5b) . RITA, Nutlin-3, MG132 and EX527 all consistently inhibited the induction of GFP-LC3 puncta by ABT737 in HeLa, U2OS and HCT116 cells (Figure 5c ). In accord with these results, which are based on the use of pharmacological inhibitors, knockdown of SIRT1 and HDM2 by specific siRNAs also blunted the autophagic response of ABT737-treated cells (Figures 5d-f) . These results underscore the complex pro-autophagic signaltransduction pathway stimulated by ABT737, which involves the obligatory activation of the deacetylase SIRT1, and the ubiquitin ligase MDM2.
Multiple signal-transduction pathways elicited by ABT737 To systematically assess the cellular signals elicited by ABT737, we determined changes in the phosphoproteome of HeLa cells treated for 2, 6 or 12 h with the BH3 mimetic, using a phosphoprotein-specific antibody array (Figures 7a and b) . ABT737 caused the hyperphosphorylation of a few proteins such as Pyk2 (confirmed by immunoblot in Figure 7c ) and AMPKa (confirmed in Figures 2 and 3) , as well as that of other proteins (such as HSP27 and Paxillin). Moreover, ABT737 triggered the dephosphorylation of several proteins: p53 on three distinct serine residues (confirmed for S392 in Figure 7c ), p70 S6K on several residues (confirmed for threonine 421/seronine 424 in Figure 2) , that of Akt (confirmed in Figure 7c ), as well as that of numerous other proteins, including transcription factors of the STAT family (in particular STAT 1 and 4), ribosomal protein S6 kinase, the cyclin-dependent kinase inhibitor, p27 (on threonine 157), and endothelial nitric oxide synthase. These results hint to multiple effects of ABT737 on a plethora of signal-transduction pathways.
The pro-autophagic activity of ABT737 might involve off-target effects. To address this possibility, we compared ABT737 with another structurally unrelated BH3 mimetic, HA14-1 (Zhang et al., 2009) . In accord with another report (Kessel and Reiners, 2007) , HA14-1 was highly efficient in inducing autophagy including in U2OS (Figures 6a and b) and HeLa cells (Figure 6c) , arguing against the possibility that ABT737 would induce autophagy through an off-target effect. Furthermore, ABT737 or HA14-1 induced LC3 lipidation, p62 degradation and GFP-LC3 redistribution to autophagic dots in control and Bax À/À Bak À/À double-knockout MEFs similarly (Figures 6d and e) . ABT737 and HA14-1 failed to induce a major loss of the mitochondrial transmembrane potential (which may be associated with apoptosis or necrosis) (Supplementary Figure 1B) . Moreover, kinetic oximetric measurements of HeLa cells treated with an autophagy-inducing concentration of ABT737 or HA14-1 failed to reveal a major impairment of any of respiratory chain complexes. In comparison, a more than 50% decrease of complex III activity could be observed in HCT116 cells at later time points (12 and 24 h) after treatment with ABT737 or HA14-1. Yet, the activity of the succinatecytochrome c reductase (which channels electrons from succinate to added cytochrome c through both complex II and III) in these cells was not significantly affected, suggesting that electron flow in the respiratory chain is only poorly impacted by the observed complex III decrease, which would then have only a reduced biological relevance. Altogether our results show that BH3 mimetics can stimulate autophagy both without inducing cell death and without impairing mitochondrial function.
In contrast to ABT737, HA14-1 exerted less dramatic changes on the phosphoproteome (data not shown), failed to induce a major decline in intracellular ATP (Supplementary Figure 1D) but induced a similar hypophosphorylation of p70 S6K , p53 on serine 393, Akt, as well as the hyperphosphorylation of AMPKa (1 mM), GA (geldanamycin; 2 mM), 17-AAG (17-allylamino-geldanamycin; 2 mM) for 12 h. Actin levels were assessed to ensure equal loading of lanes. Data are representative of three independent experiments. (b) GFP-LC3-expressing HeLa, U2OS, HCT116 cells were treated under the same conditions of (a) and the percentage of cells exhibiting the accumulation of GFP-LC3 in puncta ) is shown (means ± s.e.m., n ¼ 3). (c-e) Immunoblot detection of LC3 lipidation, as well as p62 degradation in HCT116 subjected to knockdown of IKKa, IKKb, NEMO. At 48 h after the transfection, the cells were treated with ABT737 (1 mM) for 12 h. The efficiency of siRNA-mediated downregulation of the protein is also shown. Glyceraldehyde-3-phosphate dehydrogenase levels were monitored to ensure equal loading (n ¼ 4). (f) HCT116 were transfected with unrelated (UNR) or a siRNA specific for the IKK complex subunits and subsequently (after 24 h) with a plasmid for the expression of GFP-LC3, followed by culture in the presence of ABT737 (1 mM) for 12 h (means ± s.e.m., n ¼ 3). (g) Immunoblot detection of phosphorylation status of IkBa, IKKa/b and NEMO. HCT116 cells were transfected with UNR or siRNAs specific for Atg5 and Beclin 1 as mentioned previously and treated with ABT737 (1 mM) for 12 h. The efficiency of siRNA-mediated downregulation of the proteins is also shown. Actin levels were assessed to ensure equal loading of lanes. Data are representative of three independent experiments. BH3 mimetics and autophagic pathways SA Malik et al or Pyk2 in line with specific (on-target) effects of the BH3 mimetics (Figures 7d and e) . To get insights into the molecular pathways underlying the effects of BH3 mimetics on different pro-autophagic signalling factors, we determined whether the knockdown of Vps34 or that of Beclin 1 would affect the hyperphosphorylation of AMPK (and that of its substrate ACC) or the hypophosphorylation of p70 S6K . Interestingly, although the inhibition of mTOR induced by ABT737 was inhibited by depletion of Vps34 or Beclin 1, the activation of AMPK was not affected by the knockdown of Vps34 or Beclin 1 (Figure 7f ), suggesting that ABT737 is able to modulate distinct and non-univocal pro-autophagic pathways.
Discussion
ABT737 is a highly specific BH3 mimetic (Oltersdorf et al., 2005) , trigging apoptosis in cells in which neutralization of Bcl-2 is sufficient to de-inhibit the mitochondrial cell-death pathway. Moreover, ABT737 has been shown to induce autophagy by stimulating the dissociation of Beclin 1 from its inhibitory factors Bcl-2 and Bcl-X L , thereby facilitating the Beclin 1-mediated allosteric activation of Vps34 and the consequent increase in phosphatidylinositol 3-phosphate-dependent autophagy (Maiuri et al., 2007b, c) . It appears that ABT737 activates multiple pro-autophagic signal trans- Figure 5 Involvement of p53 and SIRT1 in ABT737-induced autophagy. (a, b) Levels of LC3I/II and p62 expression in HCT116 treated with ABT737 (1 mM) for 12 h in the presence or absence of pharmacological inhibitors of MDM2 (RITA or Nutlin-3, both used at 10 mM), proteasome (MG132, 10 mM) and SIRT1 (EX527, 100 mM) (n ¼ 3). Actin and glyceraldehyde-3-phosphate dehydrogenase levels were assessed to ensure equal loading of lanes. (c) GFP-LC3-expressing HeLa, U2OS or HCT116 cells were treated under the same conditions as in (a, b) and the percentage of cells exhibiting the accumulation of GFP-LC3 in puncta ) is reported (means ± s.e.m., n ¼ 3). (d, e) Immunoblot detection of LC3 lipidation, as well as p62 degradation in HCT116 subjected to knockdown of SIRT1, HDM2 and p53. At 48 h after the transfection, the cells were treated with ABT737 for 12 h. The efficiency of siRNAmediated downregulation of the proteins is also demonstrated. Glyceraldehyde-3-phosphate dehydrogenase levels were monitored to ensure equal loading (n ¼ 5). (f) Quantification of the percentage of GFP-LC3 vac in HCT116 transfected with siRNAs specific for SIRT1, HDM2 and p53, as described in Materials and methods section, and stimulated for 12 h with ABT737 (1 mM) (means±s.e.m., n ¼ 3). duction pathways. In this article, we show that ABT737 causes the activation of AMPK, the inhibition of mTOR, dephosphorylates (and hence likewise inhibits) (Tasdemir et al., 2008b) p53, and deactivates the autophagy-inhibitory Akt kinase. These effects are obtained at comparatively high doses (in the mM range) that can be attained in vivo, in animal experiments designed to evaluate the anticancer effects of ABT737, and that induce the caspase-dependent destruction of platelets (Mason et al., 2007) . As a result, the ABT737 concentrations evaluated in this study may be clinically relevant, in spite of the fact that they are relatively high.
We considered that some of these multiple consequences of ABT737 administration might be due to offtarget effects, as ABT737 could affect proteins other than those bearing BH3 receptor domains (such as Bcl-2 and BCL-X L ) and/or act on signal-transduction pathways other than that controlled by the Beclin 1/Vps34 complex. However, ABT737 induced autophagy in cells that were fully apoptosis resistant (like MEF lacking both Bax and Bak) and failed to inhibit mitochondrial respiration before the induction of autophagy. Given this, it might be possible that a rather minor reduction in mitochondrial respiration induced by ABT737-that would be undetectable on whole cells in respirometric studies-would be perceived by homeostatic regulatory systems in the cells to stimulate autophagy, as well as a corrective increase in respiratory activity until the system decompensated. This remote possibility requires additional investigation. In spite of this caveat, knockdown of Beclin 1 or Vps34 fully suppressed ABT737-induced autophagy and also prevented the ABT737-mediated inhibition of mTOR (yet failed to affect AMPK activation induced by ABT737). In addition, several of the effects of ABT737 were shared by another structurally dissimilar BH3 mimetic, HA14-1, suggesting that the Figure 6 Pro-autophagic activity of the BH3 mimetic HA14-1. (a, b) U2OS cells stably expressing GFP-LC3 were treated with HA14-1 and the kinetics of puncta formation was determined by videomicroscopy (means±s.e.m., n ¼ 3 separate experiments). (c) Alternatively, HeLa cells were cultured in the presence of HA14-1 (20 mM) at the time points mentioned, and the lipidation of LC3 and the expression of p62 were monitored by immunoblot. Actin levels were assessed to ensure equal loading of lanes. Results are representative of three independent determinations. (d) WT and Bax À/À Bak À/À MEF were cultured in the presence of ABT737 (1 mM) or HA14-1 (20 mM) overnight, and the lipidation of LC3 and the expression of p62 were monitored by immunoblot. Actin levels were assessed to ensure equal loading of lanes. Results are representative of three independent determinations. (e) In the same conditions as shown in d, the percentage of cells exhibiting the accumulation of GFP-LC3 in puncta ) is reported (means±s.e.m., n ¼ 3). inhibition of mTOR and the dephosphorylation of p53 are specific (on-target) effects of BH3 mimetics. Thus, ABT737 may stimulate multiple autophagy-stimulatory pathways due to the high degree of connectivity that exists among autophagy-regulatory protein complexes, meaning that a specific effect on the Beclin 1 interactome might affect other nodes in the autophagycontrolling network.
Materials and methods
Cell lines and culture conditions
All cell lines were cultured at 37 1C under 5% CO 2 , in a medium containing 10% fetal calf serum, 10 mM Hepes buffer and 1 mM sodium pyruvate. In addition, cell type-specific culture conditions include Dulbecco's modified Eagle's medium (DMEM) for human cervical carcinoma HeLa cells; DMEM containing 1% non-essential amino acids for WT MEF and Bax
Bak
À/À MEF; DMEM containing 100 U/ml penicillin G sodium and 100 mg/ml streptomycin sulphate for human osteosarcoma GFP-LC3 U2OS cells; and McCoy's medium for HCT116 colon carcinoma cell lines (generous gift from B Volgelstein). All media and supplements for cell culture were purchased from Invitrogen (Carlsbad, CA, USA). Cells were seeded in 6-or 12-well plates and grown for 24 h before treatment with ABT737 (2000, 1000, 100, 10 or 1 nM; Selleck Chemicals, Houston, TX, USA), Bay11-7082 (1 mM; BioMol Research Laboratories, Lausen, Switzerland), EX527 (100 mM; Tocris Bioscience, Bristol, UK), bafilomycin A1 (BafA1; 1 nM), geldanamycin (2 mM), cisPt (10 and 20 mM), 17-allylamino-geldanamycin (2 mM), MG132 (10 mM; SigmaAldrich, St Louis, MO, USA), HA14-1 (1, 5, 10 and 20 mM), Nutlin-3 (10 mM) or RITA (10 mM; Alexis Biochemicals, Lausen, Switzerland) for the indicated period (12 h, unless otherwise stated).
Plasmids transfection and RNA interference
Transient transfections were performed with Lipofectamine 2000 reagent (Invitrogen) and cells were used 24 h after transfection unless specified differently. Cells were transfected with empty vector, Rheb D60K and Rheb Q64L (Zhou et al., 2009 ) alone or together with GFP-LC3 (Kabeya et al., 2000) . Cells were cultured in six-well plates and transfected at 50% confluence with Oligofectamine reagent (Invitrogen), in the presence of 100 nM of siRNAs specific for human SIRT1 , Atg5 (Sigma), IKKa, IKKb, NEMO (Criollo et al., 2010) , AMPKa, Beclin 1, HMD2, p53, Vps34 (Tasdemir et al., 2008b) , a scrambled siRNA or a siRNA targeting the unrelated protein emerin (Harborth et al., 2001) . siRNA-mediated protein downregulation was controlled by immunoblots.
Quantification of autophagy
Autophagy was quantified by counting the percentage of cells showing accumulation of GFP-LC3 in vacuoles, of a minimum of 100 cells per preparation in three independent experiments. Cells presenting a mostly diffuse distribution of GFP-LC3 in the cytoplasm and nucleus were considered as non-autophagic, whereas cells representing several intense punctuate GFP-LC3 aggregates with no nuclear GFP-LC3 were classified as autophagic. Each GFP-LC3 staining was read by two independent investigators. Cells cultured on coverslips were fixed in paraformaldehyde (4% w:v) for 30 min at room temperature for GFP-LC3 assays. Nuclei were labelled with Hoechst 33342 (10 mg/ml; Molecular Probes, Carlsbad, CA, USA). Fluorescence microscopy was performed with an IRE2 microscope (Leica Microsystems, Weitzler, Germany) equipped with a DC300F camera.
Automated high-content microscopy A total of 10 Â 10 3 U2OS cells stably expressing a GFP-LC3 chimera were seeded in 96-well imaging plates (BD Falcon, Oxford, UK) 24 h before treatment. The cells were cultured in the presence of ABT737 (1 mM) under standard culture conditions (37 1C, 5% CO 2 ) and subjected to pulsed observations (every 1 h for up to 36 h) with a BD pathway 855 automated live cell microscope (BD Biosciences, Oxford, UK). Images were further analyzed for the kinetics of GFP-LC3 sub-cytoplasmic count with the open source software Cellprofiler (freely available from the BROAD Institute at http://www. cellprofiler.org, Cambridge, MA, USA). Otherwise the videos of the kinetic GFP-LC3 were generated by Image J software.
Western blot analysis
Cells were washed with cold phosphate buffered saline at 4 1C and lysed on ice as described previously (Criollo et al., 2010) . In all, 40-50 mg of proteins was loaded on 4-12% or 12% SDS-PAGE precast gels (Invitrogen) and transferred to Immobilon membrane (Millipore, Billerica, MA, USA). The membranes were incubated for 1 h in phosphate-buffered saline-Tween-20 (0.05%) containing 5% non-fat milk. Primary antibodies including anti-SIRT1, -Beclin 1, -p53, -p62, -NEMO, -P-NEMO (S376), -HDM2 (Santa Cruz, Santa Cruz, CA, USA), -STAT3, -P-STAT3 (Y705), -Akt, -P-Akt (T308 and T473), -mTOR, -P-mTOR (S2448), P-p53 (S392), -IKKa, -IKKb, -P-IKKa/b (S376/180), -AMPKa, -P-AMPKa (Y172), -Pyk2, -P-Pyk2 (Y402), -IkBa, -P-IkBa (S32/36), -p70 S6K , -P-p70 S6K (Y421/S424), -Atg5, -ACC, -P-ACC (S79) or anti-LC3 (Cell Signalling, Danvers, MA, USA) were incubated overnight at 4 1C and revealed with the appropriate horseradish peroxidaselabelled secondary antibodies (Southern Biotechnologies Associates, Birmingham, AL, USA) plus the SuperSignal West Pico chemoluminescent substrate (Pierce, Rockford, IL, USA) . Antiglyceraldehyde-3-phosphate dehydrogenase (Chemicon, Billerica, MA, USA) or anti-actin (Abcam, Cambridge, MA, USA) were used to control equal loading.
Phospho-kinase array
The profile of phospho-kinase proteins was performed on HeLa cells treated with ABT737 (1 mM) and HA14-1 (20 mM) for 2, 6 and 12 h using a Proteome Profiler array-PhosphoKinase array kit (ARY003) according to the instructions of the manufacturer (R&D Systems, Minneapolis, MN, USA). Clustering was performed with MultiExperiment Viewer (MeV version 4, Boston, MA, USA). Hierarchical clustering was performed using Euclidean distance and average linkage algorithm based on their normalized phosphorylation intensities. Heatmap was generated by heatmap view integrated in MeV 4 software.
Flow cytometry
The following fluorochromes were employed to determine apoptosis-associated changes by cytofluorometry: 3,3 0 -dihexyloxacarbocyanine iodide (40 nM) for quantification or the mitochondrial transmembrane potential (Dc m ) determination and propidium iodide (1 mg/ml) for determination of cell viability (Molecular Probes) (Maiuri et al., 2007b) . Cells were trypsinized and labelled with the fluorochromes at 37 1C, followed by cytofluorometric analysis with a fluorescenceactivated cell sorter (FACS-Scan, Becton Dickinson, Franklin Lakes, NJ, USA).
Mitochondrial respiratory chain activities
Respiratory chain activities of ABT737 and HA14-1-treated cells were spectrophotometrically measured as previously described at various time points after disrupting cells by means of two freeze-thaw cycles (Rustin et al., 1994; Benit et al., 2006) .
Statistical analysis
Statistical analyses were carried out using the Prism software package (GraphPad Software Inc., San Diego, CA, USA) and the Microsoft Office 2003 Excel software package (Microsoft Corporation, Redmond, WA, USA). Mean values ± s.d. or ± s.e.m. were indicated and were compared using unpaired Student's t-tests. For multiple comparisons, we used the one-factor (ANOVA) variance analysis corrected by the Bonferroni test.
